SEATTLE, WA–(Marketwired – Jun 6, 2017) – CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Medical Marijuana, Inc.’s (OTC PINK: MJNA) fourth quarter and full year 2016 driven by its investments across several areas of the market.
Strong Investment Portfolio
Medical Marijuana, Inc. reported comprehensive income of $197,269,187 in 2016, which consisted primarily of unrealized gains on available-for-sale securities in its investment portfolio. Most of the gains came from its investment in AXIM Biotechnologies Inc. (OTCBB: AXIM) where it holds 22,669,100 shares with a market value of $231,904,893, as of June 1, 2017, when shares were trading at approximately $10.23 per share.
AXIM Biotech’s stock price has dramatically increased in value thanks to its expanding patent portfolio and near-term clinical trials. The company’s chewing gum-based cannabinoid delivery system offers superior bioavailability and extended release compared to capsules